These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18474976)

  • 1. Costs of severely ill members and specialty medication use in a commercially insured population.
    Willey VJ; Pollack MF; Lednar WM; Yang WN; Kennedy C; Lawless G
    Health Aff (Millwood); 2008; 27(3):824-34. PubMed ID: 18474976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
    Yu H; Dick AW; Szilagyi PG
    Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited options to manage specialty drug spending.
    Tu HT; Samuel DR
    Res Brief; 2012 Apr; (22):1-13. PubMed ID: 23155549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy benefit spending on oral chemotherapy drugs.
    Curtiss FR
    J Manag Care Pharm; 2006 Sep; 12(7):570-7. PubMed ID: 16981802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
    Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
    J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disability benefit coverage and program interactions in the working-age population.
    Rupp K; Davies PS; Strand A
    Soc Secur Bull; 2008; 68(1):1-30. PubMed ID: 18837269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in drug utilization for seniors without prior prescription drug insurance.
    Hudson N
    Find Brief; 2009 Mar; 12(2):1-3. PubMed ID: 19297802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study: hospitalizations increase when only generic drugs are used for Medicare Advantage members.
    Capitation Manag Rep; 2005 Mar; 12(3):30-2. PubMed ID: 15889631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial burden of health care, 2001-2004.
    Banthin JS; Cunningham P; Bernard DM
    Health Aff (Millwood); 2008; 27(1):188-95. PubMed ID: 18180494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Carving in Pharmacy Benefits on Utilization and Costs.
    Parekh N; Papa S; Drnach A; Spiegel L; Huang Y; Manolis C; Good CB
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1317-1324. PubMed ID: 32996397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability and growth in spending for outpatient specialty pharmaceuticals.
    Mullins CD; DeVries AR; Hsu VD; Meng F; Palumbo FB
    Health Aff (Millwood); 2005; 24(4):1117-27. PubMed ID: 16012152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State variations in the out-of-pocket spending burden for outpatient mental health treatment.
    Zuvekas SH; Meyerhoefer CD
    Health Aff (Millwood); 2009; 28(3):713-22. PubMed ID: 19414879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving mental health treatments through comparative effectiveness research.
    Wang PS; Ulbricht CM; Schoenbaum M
    Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States.
    Clarke AE; Yazdany J; Kabadi SM; Durden E; Winer I; Griffing K; Costenbader KH
    Semin Arthritis Rheum; 2020 Aug; 50(4):759-768. PubMed ID: 32531505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007.
    Owusu-Edusei K; Hoover KW; Tao G
    Sex Transm Dis; 2011 Mar; 38(3):175-9. PubMed ID: 20871492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actual medical and pharmacy costs for bariatric surgery: 6-year follow-up.
    Myers VH; McVay MA; Adams CE; Barbera BL; Brashear MM; Johnson WD; Boyd PS; Brantley PJ
    South Med J; 2012 Oct; 105(10):530-7. PubMed ID: 23038484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialty medications: traditional and novel tools can address rising spending on these costly drugs.
    Lotvin AM; Shrank WH; Singh SC; Falit BP; Brennan TA
    Health Aff (Millwood); 2014 Oct; 33(10):1736-44. PubMed ID: 25288417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.